Original PeptideStat dataset · updated 2026-08-03
2026 peptide vendortransparency report.
A reproducible view of source quality and documentation coverage across PeptideStat's current marketplace. This report measures what is publicly linked; it does not score product efficacy, sterility or suitability for human use.
Download listing data (CSV)Vendors
6
Listings
83
Markets
2
Direct sources
73
Exact batches
16
Named labs
5
Vendor-level coverage
Documentation, not a star score.
| Vendor | Listings | Direct price sources | Batch-linked listings | Batch records |
|---|---|---|---|---|
| Ascension PeptidesUnited States | 19 | 19 (100%) | 5 (26%) | 10 |
| Ion PeptideUnited States | 5 | 2 (40%) | 0 (0%) | 0 |
| EZ PeptidesUnited States | 16 | 13 (81%) | 0 (0%) | 0 |
| Glacier AminosUnited States | 17 | 14 (82%) | 1 (6%) | 1 |
| Nura PeptideUnited States | 15 | 14 (93%) | 0 (0%) | 0 |
| NOVA LabsUnited Arab Emirates & GCC | 11 | 11 (100%) | 11 (100%) | 5 |
Reuse and citation
Cite the date and the limitation.
Suggested citation: PeptideStat, “2026 Peptide Vendor Transparency Report,” updated 2026-08-03. When using the data, retain the checked date and distinguish vendor-linked documentation from independent product verification.